Associate Professor (Radiology, Neurology, and Psychology) |
Lab: Cognitive Neuroscience Lab
Dr. Beversdorf is currently involved in research on autism, drug abuse, dementia, cognitive effects of stress, the cognitive neuroscience of problem solving ability, functional neuroimaging, and pharmacological modulation of cognition. His work has been published in journals such as Neurology, Journal of Neurology Neuroscience and Psychiatry, Proceedings of the National Academy of Sciences of the United State of America and Lancet. He is also actively involved in the Brain Imaging Center at the University of Missouri. His research has been funded by National Institute of Neurological Diseases and Stroke, National Institute On Drug Abuse, the Stallone Fund and the National Alliance for Autism Research . He has joined the University of Missouri in the departments of Radiology, Neurology, Psychology and the Thompson Center as an Associate Professor to focus on the field of autism, with particular interest in pharmaco-functional neuroimaging as a potential treatment marker, and gene/stress interactions in the development of autism.
Dr. Beversdorf graduated from Indiana University and completed Neurology residency at Dartmouth. After his fellowship in Behavioral Neurology at University of Florida, he joined the Ohio State University faculty. He has published on memory disorders, autism, cognitive neuroscience, fMRI, neurpsychopharmacology and drug addiction. He joined the University of Missouri (Radiology, Neurology, Psychology and the Thompson Center) to focus on autism, with particular interest in pharmacofMRI as a potential treatment marker, and gene/stress interactions in autism.
1. Beversdorf DQ, Smith BW, Crucian G, Anderson JM, Keillor J, Barrett A, Hughes J, Felopulos GJ, Bauman ML, Nadeau SE, Heilman KM. Increased discrimination of “false memories” in autism spectrum disorder. Proceedings of the National Academy of Sciences. 2000:97:8734-8737.
2. Hillier A, Campbell H, Keillor J, Phillips N, Beversdorf, DQ. Decreased false memory for visually presented shapes and symbols among adults on the autism spectrum. Journal of Clinical and Experimental Neuropsychology. 2007;29:610-616.
3. Beversdorf DQ, Narayanan A, Hillier A, Hughes JD. Network model of decreased context utilization in autism spectrum disorder. J Autism Devel Disord. 2007;37:1040-1048.
4. Tivarus ME, Hillier A, Schmalbrock P, Beversdorf DQ. Functional connectivity in an fMRI study of semantic and phonological processes and the effect of L-DOPA. Brain and Language. 2008;104:42-50.
5. Beversdorf DQ, Carpenter AL, Miller RF, Cios JS, Hillier A. Effect of propranolol on verbal problem solving in autism spectrum disorder. Neurocase. 2008; 14: 378-383.
6. Heilman KM, Nadeau SE, Beversdorf DQ. Creative innovation: possible brain mechanisms. Neurocase 2003;9:369-379.
7. Tivarus ME, Ibinson JW, Hillier A, Schmalbrock P, Bevesdorf DQ. An fMRI study of semantic priming: modulation of brain activity by varying semantic distances. Cogn Behav Neurol. 2006;19:194-201.
8. Choi Y, Novak JC, Hillier A, Votolato NA, Beversdorf DQ. The effect of alpha-2 adrenergic agonists on memory and cognitive flexibility. Cognitive and Behavioral Neurology. 2006;19:204-207
9. Alexander JK, Hillier A, Smith RM, Tivarus ME, Beversdorf DQ. Beta-adrenergic modulation of cognitive flexibility during stress. Journal of Cognitive Neuroscience. 2007;19:468-478.
10. Beversdorf DQ, Ferguson JLW Hillier A, Sharma UK, Nagaraja HN, Bornstein RA, Scharre DW. Problem solving ability in patients with mild cognitive impairment. Cognitive and Behavioral Neurology. 2007;20:44-47.
11. Hillier A, Fish T, Cloppert P, Beversdorf DQ. Outcomes of a social skills support group for adolescents and young adults on the autism spectrum. Focus on Autism and Other Developmental Disabilities. 2007;22:107-115.
12. Beversdorf DQ, Sharma UK, Phillips NN, Notestine MA, Slivka AP, Friedman NM, Schneider SL, Nagaraja HN, Hillier. Effect of propranolol on naming in chronic Broca’s aphasia with anomia. Neurocase. 2007;13:256-259.
13. Campbell HL, Tivarus ME, Hillier A, Beversdorf DQ. Increased task difficulty results in greater benefit of noradrenergic modulation of cognitive flexibility. Pharmacology, Biochemistry & Behavior. 2008; 88: 222-229.
14. Kelley BJ, Yeager KR, Pepper TH, Bornstein RA, Beversdorf DQ. The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal. Neurocase. 2007;13:320-327.
15. Beversdorf DQ, Hughes JD, Heilman KM. Functional MRI of the primary somatosensory corted in extinction to simultaneous bilateral tactile stimuli due to right temporal lobe stroke. Neurocase, 2008; 14:419-424.